Yüklüyor......
3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
BACKGROUND: Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but weekly regi...
Kaydedildi:
| Yayımlandı: | Radiat Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6371614/ https://ncbi.nlm.nih.gov/pubmed/30744643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1235-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|